Navigation Links
Cadila Pharmaceuticals Launches Joint Venture With Novavax in India
Date:7/9/2009

eadquartered at Ahmedabad, in the State of Gujarat. Over the last five decades, it has been developing and manufacturing pharmaceutical products and selling and distributing these in India and in over 50 countries around the world. Cadila Pharmaceuticals is an integrated healthcare solutions provider with a pharmaceutical product basket in therapeutic areas that include cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, antidiabetics and immunologicals. The state-of-the-art Research and Development (R&D) facility at Cadila Pharmaceuticals is manned by more than three hundred and fifty scientists and engineers from various disciplines including biology, pharmacology, clinical research, chemistry, toxicology, phytochemistry and different disciplines of engineering. The company also participates in Public-Private partnerships for developing preventive and curative pharmaceutical and diagnostic products. Over the last decade, Cadila Pharmaceuticals has focused on novel approaches to cancer management and is the first Indian company to get multiple investigational new drug applications (INDs) cleared by USFDA. The company has state-of-the-art manufacturing facilities conforming to the most stringent international norms at Dholka, Ankleshwar, Kadi and Hirapur in Gujarat; Samba in Jammu and Kashmir and Addis Ababa in Ethiopia. Cadila Pharmaceuticals has recently emerged on the World map with the development of Polycap -- a novel and world's first drug combination for primary prevention of Cardiovascular Heart Disease (CHD).

About Novavax

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biotechnology company creating novel vaccines, including against pandemic H1N1 influenza, to address a broad range of infectious diseases worldwide using advanced proprietary virus-like-particle (VLP)
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India
2. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
7. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
8. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
9. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
10. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
11. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...swire-FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq: P...r27,2009astheex-dividenddateforits$200millionspeci...tiontransactioncompletedonNovember2,2009.Thedivide...cordontherecorddate,December1,2009.NASDAQhassetthe...areofcommonstockforpurposesoftheex-dividenddateonN...
(Date:11/23/2009)... Sporicidin disinfectant solution and wipes are re...against H1N1 and Influenza A., , ...-- Contec Inc, the leading manufacturer of clean ...in disinfectants have been deemed by the EPA as e...g Pandemic 2009 H1N1 influenza A virus (the swine ...
(Date:11/23/2009)...swire/--Frost&Sullivan,theGrowthPartnershipCom...dershipandinnovationThursday,November19,2009attheE...SanAntonio,Texas. ,, (Logo: http://www.newscom....careInnovationAwardsaregiventocompaniesthathavemad...tofhealthcare.Suchcompanieshaveshownsuccessatmeeti...
(Date:11/20/2009)..., , , , , , , ,... of scientists from Washington University in St. L...r Laboratory and Iowa State University has finishe... Click here for more information. , ,... , , , , , , , , ,...
Breaking Biology Technology:PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4
...ORONTO, Jan. 29 /PRNewswire-FirstCall/ - ARIUS Res...scovering and developing the next wave of,antibody...perational,results for the fourth quarter and fisc...as a critical year in our development, highlighted...re-IND programs for our lead drug,candidates, our ...
... CHAMPAIGN, Ill. Carbon nanotubes have a sound f... who built the worlds first all-nanotube transisto...ch nanotube devices provide all of the active func...t steps toward the practical implementation of car...tronics and other related applications, said John ...
..., Troy, N.Y. Researchers at Rensselaer Polytechn...new inexpensive, quick-drying polymer that could l...in semiconductor manufacturing and computer chip p...nce and cost savings for conventional photolithogr...poxy siloxane (PES), should also enable a new gene...
Other Biology Technology:ARIUS announces fourth quarter and year-end fiscal 2007 financial results 2ARIUS announces fourth quarter and year-end fiscal 2007 financial results 3ARIUS announces fourth quarter and year-end fiscal 2007 financial results 4ARIUS announces fourth quarter and year-end fiscal 2007 financial results 5ARIUS announces fourth quarter and year-end fiscal 2007 financial results 6ARIUS announces fourth quarter and year-end fiscal 2007 financial results 7ARIUS announces fourth quarter and year-end fiscal 2007 financial results 8ARIUS announces fourth quarter and year-end fiscal 2007 financial results 9ARIUS announces fourth quarter and year-end fiscal 2007 financial results 10ARIUS announces fourth quarter and year-end fiscal 2007 financial results 11ARIUS announces fourth quarter and year-end fiscal 2007 financial results 12ARIUS announces fourth quarter and year-end fiscal 2007 financial results 13New kind of transistor radios shows capability of nanotube technology 2New polymer could improve semiconductor manufacturing, packaging 2
(Date:11/23/2009)...community-associated strain of the deadly superbug...st common antibioticsposes a far greater health th...nto hospitals, according to a study in the Decembe...e new threat is easily picked up in fitness center...sed the overall burden of MRSA within hospitals, t...
(Date:11/23/2009)..., 2009 - The time of day matters to forest trees d...uced by a research team led by Professor Malcolm C...principal for research and colleagues in the depar...e campus. , Capitalizing on their previous wor...earch team examined how poplar trees use their 45,...
(Date:11/23/2009)... than 160 participants gathered this week for the ...TIATIVE conference. This year,s topic, "Synthetic ...and medical researchers to explore the engineering...erging field of synthetic biology. , Bonnie L. B...n University and this year,s conference chair, cha...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2AbbeyMoor Medical Receives FDA Approval for Design Improvements to The Spanner 28TM 29 Prostatic Stent 50785 1CareMedic and Cincom Sign OEM Technology Partnership for Healthcare Solution 50783 1CareMedic and Cincom Sign OEM Technology Partnership for Healthcare Solution 50783 2Research Reveals Clues to Breast Cancers Spread 50781 1Research Reveals Clues to Breast Cancers Spread 50781 2
...With an incredible lifespan of up to 250 years the...ng the longest-lived of all animals, but how it ob...- to keep going for this long has been a mystery. ...ss online journal PLoS Biology, Erik Cordes and co...waste sulfate not up into the ocean but down into ...
...For the first time, scientists have replicated hep...y to replicate HCV in cell culture will allow rese... of this virus and to test potential antiviral com...ver disease that results from infection with HCV. ...nd Digestive and Kidney Diseases (NIDDK), one of t...
...When the most common adult leukemia in the United ...l of Medicine (NEJM) in 1995, it was seen through ... As such, the journal recently invited three of th...leukemia (CLL) to write an authoritative update co...ity,s knowledge of CLL that has occurred over the ...
Other Biology News: The secret to longevity in tubeworms 2Scientists Replicate Hepatitis C Virus in Laboratory 2Recent breakthroughs in common adult leukemia highlighted in New England Journal of Medicine 2
RAOSMC (R354-05) from European Collection of Cell Cultures (ECACC)
BlueView Nucleic Acid Stain from Sigma-Aldrich
REK (R102-05) from European Collection of Cell Cultures (ECACC)
... long been a molecule of fascination, being the pr...tive peptides such as ACTH, -Lipotrophin (-LPH), -...-MSH) and more. It is also a very well-conserved m...including those "living fossils", the lungfish. Th...
Biology Products: